Literature DB >> 26349310

Bombesin Encapsulated in Long-Circulating pH-Sensitive Liposomes as a Radiotracer for Breast Tumor Identification.

André Luís Branco De Barros, Luciene Das Graças Mota, Marina Melo Antunes Coelho, Natássia Caroline Resende Corrêa, Alfredo Miranda De Góes, Mônica Cristina Oliveira, Valbert Nascimento Cardoso.   

Abstract

Bombesin (BBN) is a tetradecapeptide that binds specifically to gastrin-releasing peptide receptors in humans. These receptors are over-expressed in several forms of cancer; radiolabeled BBN could therefore be used to detect such cancers. However, the degradation of peptides is a critical issue in the development of tumor tracers. Liposomes can be used to overcome this problem and improve the uptake of tracers by tumors. Therefore, the purpose of this study was to prepare and characterize long-circulating and pH-sensitive liposomes (SpHL) containing 99mTc-HYNIC-βAla-Bombesin(7-14) (99mTc-BBN(7-14). In addition, the ability of this system to identify human breast cancer tissue was evaluated using biodistribution studies and scintigraphic images. Long-circulating and pH-sensitive liposomes (SpHL) were prepared and freeze-dried in the presence of cryoprotectants (glucose, mannitol, and trehalose). They were subsequently reconstituted with a solution of 99mTc-HYNIC-βAla-Bombesin(7-14) (99mTc-BBN(7-14)). The liposomes were evaluated for size, encapsulation percentage, radiotracer leakage, and storage stability. In addition, in vivo studies were performed in breast tumor-bearing nude mice. Liposomes in the presence of glucose (SpHLG), exhibited a mean diameter of 164.5 ± 6.5 nm and exhibited a 99mTc-BBN(7-14) encapsulation percentage of 30%. In addition, they remained highly stable for up to 120 days of storage. SpHLG- 99mTc-BBN(7-14) showed longer blood circulation than free 99mTc-BBN(7-14), did. The tumor-to-muscle and tumor-to-blood ratios for SpHLG-99mTc-BBN(7-14 were high at 4 h post-injection (9.31%ID/g and 7.93%ID/g, respectively). Furthermore, scintigraphic images revealed a strong signal in the tumor area, indicating tumor specificity of SpHLG-99mTc-BBN(7-14). In summary, SpHLG-99mTc-BBN(7-14) presented characteristics suitable for a diagnostic agent, and is a potential tool for tumor identification.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26349310     DOI: 10.1166/jbn.2015.1910

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  7 in total

1.  Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.

Authors:  Parham Sahandi Zangabad; Soroush Mirkiani; Shayan Shahsavari; Behrad Masoudi; Maryam Masroor; Hamid Hamed; Zahra Jafari; Yasamin Davatgaran Taghipour; Hura Hashemi; Mahdi Karimi; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2017-12-12       Impact factor: 7.848

Review 2.  Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.

Authors:  Paola Moreno; Irene Ramos-Álvarez; Terry W Moody; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2016-03-28       Impact factor: 6.902

3.  pH-Sensitive, Long-Circulating Liposomes as an Alternative Tool to Deliver Doxorubicin into Tumors: a Feasibility Animal Study.

Authors:  Juliana O Silva; Renata S Fernandes; Sávia C A Lopes; Valbert N Cardoso; Elaine A Leite; Geovanni D Cassali; Maria Cristina Marzola; Domenico Rubello; Monica C Oliveira; Andre Luis Branco de Barros
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

4.  Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study.

Authors:  Liziane O F Monteiro; Renata S Fernandes; Caroline M R Oda; Sávia C Lopes; Danyelle M Townsend; Valbert N Cardoso; Mônica C Oliveira; Elaine A Leite; Domenico Rubello; André L B de Barros
Journal:  Biomed Pharmacother       Date:  2017-11-06       Impact factor: 6.529

5.  Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivo.

Authors:  Liziane O F Monteiro; Renata S Fernandes; Luciano C Castro; Valbert N Cardoso; Mônica C Oliveira; Danyelle M Townsend; Alice Ferretti; Domenico Rubello; Elaine A Leite; André L B de Barros
Journal:  Biomed Pharmacother       Date:  2017-03-24       Impact factor: 6.529

6.  pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment.

Authors:  Shirleide Santos Nunes; Sued Eustaquio Mendes Miranda; Juliana de Oliveira Silva; Renata Salgado Fernandes; Janaína de Alcântara Lemos; Carolina de Aguiar Ferreira; Danyelle M Townsend; Geovanni Dantas Cassali; Mônica Cristina Oliveira; André Luís Branco de Barros
Journal:  Biomed Pharmacother       Date:  2021-10-08       Impact factor: 7.419

Review 7.  Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment.

Authors:  Jafrin Jobayer Sonju; Achyut Dahal; Sitanshu S Singh; Seetharama D Jois
Journal:  J Control Release       Date:  2020-10-01       Impact factor: 9.776

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.